Eagle Pharmaceuticals Cash from Financing (TTM) Trends

Eagle Pharmaceuticals Inc (EGRX)

4.54 -0.09 (-1.94%) USD | NASDAQ | May 10, 16:00

4.54 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2023	11.92M
March 31, 2023	17.80M
December 31, 2022	-6.209M
September 30, 2022	-18.71M
June 30, 2022	-32.05M
March 31, 2022	-36.73M
December 31, 2021	-28.39M
September 30, 2021	-24.39M
June 30, 2021	-38.31M
March 31, 2021	-147.94M
December 31, 2020	-37.87M
September 30, 2020	-35.86M
June 30, 2020	-13.13M
March 31, 2020	85.49M
December 31, 2019	-24.22M
September 30, 2019	-70.58M
June 30, 2019	-82.03M
March 31, 2019	-66.88M
December 31, 2018	-88.12M
September 30, 2018	-43.73M

Date	Value
June 30, 2018	4.788M
March 31, 2018	-3.787M
December 31, 2017	8.104M
September 30, 2017	-4.246M
June 30, 2017	-55.33M
March 31, 2017	-45.67M
December 31, 2016	-33.67M
September 30, 2016	-14.86M
June 30, 2016	0.386M
March 31, 2016	0.553M
December 31, 2015	55.81M
September 30, 2015	55.46M
June 30, 2015	55.53M
March 31, 2015	54.94M
December 31, 2014	46.69M
September 30, 2014	46.15M
June 30, 2014	46.07M
March 31, 2014	56.40M
December 31, 2013	9.311M
September 30, 2013	9.809M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-147.94M

Minimum

Mar 2021

85.49M

Maximum

Mar 2020

-28.31M

Average

-28.39M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks